(Q34126724)

English

Renal function declines more in tenofovir- than abacavir-based antiretroviral therapy in low-body weight treatment-naïve patients with HIV infection

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Renal function declines more in tenofovir- than abacavir-based antiretroviral therapy in low-body weight treatment-naïve patients with HIV infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

anti-retroviral agent

0 references

1 reference

based on heuristic

inferred from title

Hirohisa Yazaki

object named as

Hirohisa Yazaki

11

0 references

author name string

Takeshi Nishijima

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Hiroyuki Gatanaga

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Hirokazu Komatsu

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Kunihisa Tsukada

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Takuro Shimbo

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Takahiro Aoki

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Koji Watanabe

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Ei Kinai

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Haruhito Honda

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Junko Tanuma

10

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Miwako Honda

12

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Katsuji Teruya

13

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Yoshimi Kikuchi

14

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Shinichi Oka

15

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

5 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

e29977

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

copyright license

Creative Commons Attribution 4.0 International

5 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Impact of small body weight on tenofovir-associated renal dysfunction in HIV-infected patients: a retrospective cohort study of Japanese patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252345

28 July 2018

Relationship between renal dysfunction, nephrotoxicity and death among HIV adults on tenofovir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252345

28 July 2018

Renal safety of a tenofovir-containing first line regimen: experience from an antiretroviral cohort in rural Lesotho

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252345

28 July 2018

Incidence and risk factors for tenofovir-associated renal function decline among Thai HIV-infected patients with low-body weight

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252345

28 July 2018

Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252345

28 July 2018

Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252345

28 July 2018

Renal function with use of a tenofovir-containing initial antiretroviral regimen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252345

28 July 2018

Defining incident chronic kidney disease in the research setting: The ARIC Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252345

28 July 2018

Tenofovir renal toxicity targets mitochondria of renal proximal tubules

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252345

28 July 2018

Recent developments in HIV and the kidney

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252345

28 July 2018

The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252345

28 July 2018

Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252345

28 July 2018

Pharmacogenetic information derived from analysis of HLA alleles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252345

28 July 2018

HLA-B*5701 screening for hypersensitivity to abacavir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252345

28 July 2018

Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252345

28 July 2018

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252345

28 July 2018

Population pharmacokinetics of tenofovir in human immunodeficiency virus-infected patients taking highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252345

28 July 2018

Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252345

28 July 2018

Pharmacogenetics: a practical role in predicting antiretroviral drug toxicity?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252345

28 July 2018

Prediction of creatinine clearance from serum creatinine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252345

28 July 2018

Fanconi syndrome and renal failure induced by tenofovir: a first case report

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029977

21 January 2018

Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029977

21 January 2018

Progressive renal tubular dysfunction associated with long-term use of tenofovir DF.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029977

21 January 2018

Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029977

21 January 2018

Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029977

21 January 2018

Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029977

21 January 2018

Urinary beta2-microglobulin as a possible sensitive marker for renal injury caused by tenofovir disoproxil fumarate.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029977

21 January 2018

Changes in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215).

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029977

21 January 2018

Serum phosphate but not pulse wave velocity predicts decline in renal function in patients with early chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029977

21 January 2018

Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029977

21 January 2018

The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029977

21 January 2018

Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029977

21 January 2018

Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252345

28 October 2018

Incidence of abacavir hypersensitivity and its relationship with HLA-B*5701 in HIV-infected patients in Taiwan

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029977

21 January 2018

No change in calculated creatinine clearance after tenofovir initiation among Thai patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029977

21 January 2018

Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America

1 reference

https://pubmed.ncbi.nlm.nih.gov/22242194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0029977

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

2012PLoSO...729977N

0 references

release_zomp6xuppnbabj6irk24xh4x2m

1 reference

https://api.fatcat.wiki/v0/release/zomp6xuppnbabj6irk24xh4x2m

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34126724&oldid=1868409314"